Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.

Oncotarget · 2017 · PMC5685717 · PMID 29163796

Europe PMC DOI

hedged sentence

0.0557

closest p · 1.1× alpha

0.0557

boldest claim

The sentences

showed a trendP = 0.0557so close (0.05 < p ≤ 0.1)

Strong PAI-1 staining also showed a trend toward worse overall survival (OS) compared to weak PAI-1 expression (median OS, 27.0 vs. 37.0 months, P = 0.0557; Figure 1C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.